Condensed Consolidated Statements of Operations and Comprehensive Gain/Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
REVENUES	$ 2,168,004	$ 414,584
COST OF REVENUES	1,575,743	332,299
GROSS PROFIT(LOSS)	592,261	82,285
OPERATING EXPENSES:
Sales and marketing	452,636	41,070
General and administrative	3,380,014	1,364,952
Total operating expenses	3,832,650	1,406,022
LOSS FROM OPERATIONS	(3,240,389)	(1,323,737)
OTHER INCOME (EXPENSE)
Interest expense	44,355	21,684
Other (income)/ expense	(12,865)	545
Total other income (expense), net	(31,490)	(22,229)
LOSS BEFORE INCOME TAXES	(3,271,879)	(1,345,966)
PROVISION FOR INCOME TAXES	18,748	1,268
NET LOSS FROM CONTINUING OPERATIONS	(3,290,627)	(1,347,234)
DISCONTINUED OPERATIONS
Income/(loss) from operations of discontinued operations		(854,957)
NET LOSS	(3,290,627)	(2,202,191)
Less: net income (loss) attributable to non-controlling interest	42,615	(7,316)
NET LOSS ATTRIBUTABLE TO BOQI INTERATIONAL MEDICAL INC.	(3,333,242)	(2,194,875)
OTHER COMPREHENSIVE LOSS
Foreign currency translation adjustment	(149,597)	(120,201)
TOTAL COMPREHENSIVE LOSS	(3,440,224)	(2,322,392)
Less: comprehensive loss attributable to non-controlling interests	(10,886)	(4,935)
COMPREHENSIVE LOSS ATTRIBUTABLE TO BOQI INTERNATIONAL MEDICAL INC.	$ (3,429,338)	$ (2,317,457)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
Basic and diluted (in Shares)	16,693,038	9,271,641
INCOME (LOSS) PER SHARE
Continuing operation-Basic and diluted (in Dollars per share)	$ (0.20)	$ (0.15)
Discontinued operation-Basic and diluted (in Dollars per share)		(0.09)
Basic and diluted (in Dollars per share)	$ (0.20)	$ (0.24)